Hydrophobic benzoic acids as inhibitors of influenza neuraminidase.

Neuraminidase (NA) plays a critical role in the life cycle of influenza virus and is a target for new therapeutic agents. A new benzoic acid inhibitor (11) containing a lipophilic side chain at C-3 and a guanidine at C-5 was synthesized. The X-ray structure of 4-(N-acetylamino)-5-guanidino-3-(3-pentyloxy)benzoic acid in complex with NA revealed that the lipophilic side chain binds in a newly created hydrophobic pocket formed by the movement of Glu 278 to interact with Arg 226, whereas the guanidine of 11 interacts in a negatively charged pocket created by Asp 152, Glu 120 and Glu 229. Compound 11 was highly selective for type A (H2N2) influenza NA (IC50 1 microM) over type B (B/Lee/40) influenza NA (IC50 500 microM).

[1]  B. Jin,et al.  The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor. , 1994, Carbohydrate research.

[2]  W G Laver,et al.  Guanidinobenzoic acid inhibitors of influenza virus neuraminidase. , 1997, Journal of molecular biology.

[3]  N R Taylor,et al.  Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B. , 1998, Journal of medicinal chemistry.

[4]  D. M. Ryan,et al.  Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.

[5]  A Merritt,et al.  Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides. , 1998, Journal of medicinal chemistry.

[6]  M. Itzstein,et al.  A convenient method for the introduction of nitrogen and sulfur at C-4 on a sialic acid analogue , 1993 .

[7]  G. Air,et al.  Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding , 1995, Journal of virology.

[8]  G. Air,et al.  Structure of influenza virus neuraminidase B/Lee/40 complexed with sialic acid and a dehydro analog at 1.8-A resolution: implications for the catalytic mechanism. , 1994, Biochemistry.

[9]  W G Laver,et al.  GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains. , 1998, Biochemical and biophysical research communications.

[10]  G. Air,et al.  Site-directed mutagenesis of catalytic residues of influenza virus neuraminidase as an aid to drug design. , 1998, European journal of biochemistry.

[11]  H. Klenk,et al.  The Molecular Biology of Influenza Virus Pathogenicity , 1988, Advances in Virus Research.

[12]  S Cusack,et al.  The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. , 1992, The EMBO journal.

[13]  P. Colman,et al.  Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution. , 1991, Journal of molecular biology.

[14]  P. Colman,et al.  Three‐dimensional structure of the complex of 4‐guanidino‐Neu5Ac2en and influenza virus neuraminidase , 1995, Protein science : a publication of the Protein Society.

[15]  Taylor Nr,et al.  Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis. , 1994 .

[16]  A. van Donkelaar,et al.  Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants. , 1992, Journal of molecular biology.

[17]  R. Compans,et al.  Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. , 1974, Virology.

[18]  Paul W Smith,et al.  Novel inhibitors of influenza sialidase related to GG167 Synthesis of 4-amino and guanidino-4H-pyran-2-carboxylic acid-6-propylamides; selective inhibitors of influenza a virus sialidase , 1996 .

[19]  E. D. Kilbourne,et al.  Protective Effects of Specific Immunity to Viral Neuraminidase on Influenza Virus Infection of Mice , 1968, Journal of virology.

[20]  S. Swaminathan,et al.  Synthesis and influenza neuraminidase inhibitory activity of aromatic analogues of sialic acid , 1995 .

[21]  G. Air,et al.  The neuraminidase of influenza virus , 1989, Proteins.

[22]  G. Air,et al.  Influenza virus neuraminidase with hemagglutinin activity. , 1984, Virology.

[23]  W G Laver,et al.  Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. , 1997, Journal of the American Chemical Society.

[24]  J. N. Varghese,et al.  Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution , 1983, Nature.

[25]  G. Air,et al.  Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. , 1995, Journal of medicinal chemistry.

[26]  W G Laver,et al.  Structures of aromatic inhibitors of influenza virus neuraminidase. , 1995, Biochemistry.

[27]  P. Warrener,et al.  RNA-stimulated NTPase activity associated with the p80 protein of the pestivirus bovine viral diarrhea virus. , 1993, Virology.

[28]  G. Air,et al.  Three‐dimensional structure of neuraminidase of subtype N9 from an avian influenza virus , 1987, Proteins.

[29]  W G Laver,et al.  Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid. , 1994, Journal of molecular biology.

[30]  P. Palese,et al.  Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. , 1974, Virology.